MARIO SGRO

Fondatore di Il Nuovo Mosaico 2023

Chi è Mario Sgro?

Dr. Lupi Alessandro

Lupi Alessandro

Istruzione e formazione

  • 1982-1987: LICEO CLASSICO
    Lingua Italiana, Latina, Greca, Inglese; Scienze Umanistiche; Matematica, Fisica, Storia Dell’Arte.
    Diploma Di Maturità Classica 60/60
  • 1987-1993: Corso Di Laurea In Medicina E Chirurgia C/O Università Cattolica Del Sacro Cuore Di Roma (Policlinico Gemelli) Medicina E Chirurgia
  • Laurea In Medicina e Chirurgia: 110/110 Con Lode, Premio “Ludovico Necchi” Come Miglior Laureato Per L’Anno Accademico 1992-1993
  • 1993-1998: Corso Di Specializzazione In Cardiologia C/O Università Cattolica Del Sacro Cuore Di Roma (Policlinico Gemelli) Specializzazione In Cardiologia E Malattie Dell’Apparato Cardiovascolare (Cardiologia Clinica, Ecocardiografia, Ecografia Vascolare, Terapia Intensiva Coronarica E Dello Scompenso, Elettrofisiologia Di Base, Emodinamica E Cardiologia Interventistica) Specializzazione In Cardiologia 100/100 Con Lode
  • Capacità e Competenze Relazionali:
    1) Giocatore E Poi Allenatore di Squadra di Basket Cat Dilettanti (I° Divisione) Dal 1982 Al 1992
    2) Esperienza Pluridecennale Di Medico Ospedaliero Con Intenso Contatto Con L’Utenza E Con I Colleghi
  • Capacità e Competenze Organizzative
    Capacità Dirigenziali ed Organizzative, Acquisite Con le esperienze di responsabile del servizio di Ecocardiografia C/O Campus Biomedico nel 1999, di responsabile del laboratorio di Emodinamica Dell’Ospedale di Aosta (Ruolo Ricoperto dal 2000 Al 2007) e di responsabile del laboratorio di Emodinamica Ospedaliera Dell’Aou Maggiore Della Carità Di Novara (Ruolo tutt’ora ricoperto). Capacità organizzative per l’organizzazione di corsi e congressi, in cui e’ stata maturata esperienza decennale Cardiologo Interventista Esperto Ecocardiografista, Esperto di informatica medica e biostatistica membro dello scientific board della rivista “Clinical Medicine Insights: Cardiology” buona capacità di scrittura scientifica pubblicistica e creativa buone capacità di disegno a mano libera

Esperienza lavorativa

  • 1996-1997: Aeronautica Militare Italiana Pubblica, Forze armate Dirigente Medico. Dirigente Medico di infermeria aeroportuale, Medicina Legale
  • 1998-1999: Università Campus Biomedico, ROMA Azienda Universitaria, Sanità Pubblica, Assistente Medico a contratto, Responsabile del Laboratorio di Ecocardiografia
  • 1999 – 2007: USL Valle d’Aosta, Via Guido Rey 1 11100 Aosta; Ospedale Generale Regionale Generale, Sanità Pubblica; Dirigente Medico I° livello SSN; Dal 2001 Responsabile del Laboratorio di Emodinamica
  • 2007 – MAR 2016: AOU Maggiore della Carità, Cso Mazzini 18, 28100 Novara; Ospedale Universitario, Sanità Pubblica; Dirigente Medico I° livello SSN, incarico di Alta Specialità in; Cardiologia Invasiva; Dal 2012 Responsabile del Laboratorio di Emodinamica
  • Nome e indirizzo del datore di lavoro: ASL VCO, Via Mazzini 117, 28887 Omegna (VB); Ospedale Universitario, Sanità Pubblica; Dirigente Medico II° livello SSN, Direttore della SOC; Cardiologia Ospedali Riuniti di VERBANIA e DOMODOSSOLA
  • GEN 2018 – GEN 2010: CFC – Italian Council of Cardiology Practice on behalf of ESC; Presidente Nazionale eletto per il biennio 2018-2010
  • GEN 2019 – OGGI: Scuola di Medicina Università dell’Insubria (VA); Docente di “Scompenso cardiaco e cardiomiopatie” per la Scuola di Specializzazione di Cardiologia

Elenco Pubblicazioni:

1) Lupi A, Ferrari I, Persampieri S, Ariotti S, De Pace D, Gaudio GV, Guasti L, De Ponti R. Early Administration of Sacubitril/Valsartan is Associated with more Rapid NT proBNP Recovery in High-Risk Patients Hospitalized for Acute Heart Failure. Medical Research Archives, 2023 May; 11 (5): 2375-1924. doi: https://doi.org/10.18103/mra.v11i4.3714
2) Olmastroni E, Gazzotti M, Averna M, Arca M, Tarugi P, Calandra S, Bertolini S, Catapano AL, Casula M; LIPIGEN Study Group *. Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia. J Am Heart Assoc. 2023 May 16;12(10):e029223. doi: 10.1161/JAHA.122.029223. Epub 2023 May 15. PMID: 37183858; PMCID: PMC10227296.
3) Iannaccone M, DE Filippo O, Montabone A, Marengo G, Maltese L, Ugo F, Quadri G, Mennuni M, Secco GG, Taglialatela V, Cinconze S, Moretti C, Truffa A, Gambino A, Boccuzzi G, Infantino V, Conrotto F, Lupi A, Varbella F, Patti G, Rognoni A, Musumeci G, Prati F, DE Ferrari GM, D’Ascenzo F. OCT guided vs. COmplete pci in patieNts with sT segment elevation myocArdial infarCtion and mulTivessel disease: OCT-CONTACT RCT. Minerva Cardiol Angiol. 2023 Aug;71(4):431-437. doi: 10.23736/S2724-5683.22.06144-0. Epub 2023 Feb 27. PMID: 36847434.
4) Fagiuoli S, Toniutto P, Coppola N, Ancona DD, Andretta M, Bartolini F, Ferrante F, Lupi A, Palcic S, Rizzi FV, Re D, Alvarez Nieto G, Hernandez C, Frigerio F, Perrone V, Degli Esposti L, Mangia A. Italian Real-World Analysis of the Impact of Polypharmacy and Aging on the Risk of Multiple Drug-Drug Interactions (DDIs) in HCV Patients Treated with Pangenotypic Direct-Acting Antivirals (pDAA). Ther Clin Risk Manag. 2023 Jan 18;19:57-65. doi:10.2147/TCRM.S394467. PMID: 36699017; PMCID: PMC9868280.
5) Polimeni A, Spaccarotella C, Ielapi J, Esposito G, Ravera A, Martuscelli E, Ciconte V, Menichelli M, Varbella F, Imazio M, Navazio A, Sinagra G, Oberhollenzer R, Sibilio G, Cacciavillani L, Meloni L, Dominici M, Tomai F, Amico F, Corda M, Musumeci G, Lupi A, Zezza L, De Caterina R, Cernetti C, Metra M, Rossi L, Calabrò P, Murrone A, Volpe M, Caldarola P, Carugo S, Cortese B, Valenti R, Boriani G, Fedele F, Ventura G, Manes MT, Colavita AR, Feola M, Versaci F, Assennato P, Arena G, Ceravolo R, Amodeo V, Tortorici G, Nassiacos D, Antonicelli R, Esposito N, Favale S, Licciardello G, Tedesco L, Indolfi C. The impact of UEFA Euro 2020 football championship on Takotsubo Syndrome: Results of a multicenter national registry. Front Cardiovasc Med. 2022 Sep 28;9:951882. doi: 10.3389/fcvm.2022.951882. PMID: 36247479; PMCID: PMC9554214.
6) Perrone V, Veronesi C, Dovizio M, Ancona DD, Bartolini F, Ferrante F, Lupi A, Palcic S, Re D, Terlizzi AP, Ramirez de Arellano Serna A, Cogliati P, Degli Esposti L. The Influence of Iron-Deficiency Anaemia (IDA) Therapy on Clinical Outcomes and Healthcare Resource Consumptions in Chronic Kidney Disease Patients Affected by IDA: A Real-Word Evidence Study among the Italian Population. J Clin Med. 2022 Sep 30;11(19):5820. doi: 10.3390/jcm11195820. PMID: 36233688; PMCID: PMC9573467.
7) Perrone V, Giacomini E, Sangiorgi D, Andretta M, Bartolini F, Lupi A, Ferrante F, Palcic S, Re D, Degli Esposti L. Evaluation of the Therapeutic Pattern and Pharmaco Utilization in Hypercholesterolemic Patients Treated with Statins: A Retrospective Study on Italian Real-World Data. Risk Manag Healthc Policy. 2022 Jul 28;15:1483-1489. doi: 10.2147/RMHP.S358015. PMID: 35923556; PMCID: PMC9342867.
8) Perrone V, Dovizio M, Veronesi C, Andretta M, Bartolini F, Cavaliere A, Ferrante F, Lupi A, Pagliaro R, Pagnotta R, Palcic S, Re D, Ubertazzo L, Vercellone A, Degli Esposti L. Real-World Evaluation of Calcimimetics for the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease, in an Italian Clinical Setting. Healthcare (Basel). 2022 Apr 11;10(4):709. doi: 10.3390/healthcare10040709. PMID: 35455886; PMCID: PMC9025876.
9) Olmastroni E, Gazzotti M, Arca M, Averna M, Pirillo A, Catapano AL, Casula M; LIPIGEN Study Group†. Twelve Variants Polygenic Score for Low-Density Lipoprotein Cholesterol Distribution in a Large Cohort of Patients With Clinically Diagnosed Familial Hypercholesterolemia With or Without Causative Mutations. J Am Heart Assoc. 2022 Apr 5;11(7):e023668. doi: 10.1161/JAHA.121.023668. Epub 2022 Mar 24. PMID: 35322671.
10) Persampieri S, Castini D, Lupi A, Guazzi M. Untangling the difficult interplay between ischemic and hemorrhagic risk: The role of risk scores. World J Cardiol. 2022 Feb 26;14(2):96-107. doi: 10.4330/wjc.v14.i2.96. PMID: 35316974; PMCID: PMC8900521.
11) Degli Esposti L, Veronesi C, Ancona DD, Andretta M, Bartolini F, Drei A, Lupi A, Palcic S, Re D, Rizzi FV, Giacomini E, Perrone V. Direct Healthcare Costs by Level of Adherence of a Real-World Population of Statin Users in Italy. Clinicoecon Outcomes Res. 2022 Mar 10;14:139-147. doi 10.2147/CEOR.S345852. PMID: 35299992; PMCID: PMC8922236.
12) De Pace D, Ariotti S, Persampieri S, Patti G, Lupi A. Unexpected Pulmonary Embolism Late After Recovery from Mild COVID-19? Eur J Case Rep Intern Med. 2021 Dec 21;8(12) 002854. doi: 10.12890/2021_002854. PMID: 35059331; PMCID: PMC8765695.
13) Bianchi V, Bisignani G, Migliore F, Biffi M, Nigro G, Viani S, Caravati F, Checchi L, Francia P, De Filippo P, Pecora D, Lavalle C, Scalone A, Rossi P, Palmisano P, Licciardello G, Ospizio R, Lovecchio M, Valsecchi S, D’Onofrio A; “S-ICD Rhythm Detect” Investigators. Safety of Omitting Defibrillation Efficacy Testing With Subcutaneous Defibrillators: A Propensity-Matched Case-Control Study. Circ Arrhythm Electrophysiol. 2021 Dec;14(12):e010381. doi:10.1161/CIRCEP.121.010381. Epub 2021 Dec 2. PMID: 34852635.
14) EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC). Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC). Lancet. 2021 Nov 6;398(10312):1713-1725. doi: 10.1016/S0140-6736(21)01122-3. Epub 2021 Sep 7. PMID: 34506743.
15) Lupi A, Ariotti S, De Pace D, Ferrari I, Bertuol S, Monti L, Guasti L, Gaudio GV, Campana C. Sacubitril/Valsartan to Treat Heart Failure in a Patient with Relapsing Hairy Cell Leukaemia: Case Report. Clin Med Insights Cardiol. 2021 Apr 13;15:11795468211010706. doi:10.1177/11795468211010706. PMID: 33911910; PMCID:PMC8050758.
16) Tarantini G, Mojoli M, Varbella F, Caporale R, Rigattieri S, Andò G, Cirillo P, Pierini S, Santarelli A, Sganzerla P, De Cesare N, Limbruno U, Lupi A, Ricci R, Cernetti C, Favero L, Saia F, Roncon L, Gasparetto V, Ferlini M, Ronco F, Ferri L, Trabattoni D, Russo A, Guiducci V, Penzo C, Tarantino F, Mauro C, Marchese A, Castiglioni B, La Manna A, Martinato M, Gregori D, Angiolillo DJ, Musumeci G. Downstream or upstream administration of P2Y12 receptor blockers in non-ST elevated acute coronary syndromes: study protocol for a randomized controlled trial. Trials. 2020 Nov 24;21(1):966. doi:10.1186/s13063-020-04859-1. PMID: 33234137; PMCID: PMC7686679.
17) Guasti L, Galliazzo S, Molaro M, Visconti E, Pennella B, Gaudio GV, Lupi A, Grandi AM, Squizzato A. TMAO as a biomarker of cardiovascular events: a systematic review and meta-analysis. Intern Emerg Med. 2021 Jan;16(1):201-207. doi: 10.1007/s11739-020-02470-5. Epub 2020 Aug 10. PMID: 32779113.
18) Persampieri S, Schaffer A, De Martino L, Valli F, Lupi A. Alcohol Consumption and Acute Coronary Syndrome: “In vino Veritas”. Cardiology. 2020;145(12):766-768. doi: 10.1159/000509417. Epub 2020 Aug 7. PMID: 32772014.
19) Derosa G, Colletti A, Maffioli P, D’Angelo A, Lupi A, Zito GB, Mureddu GF, Raddino R, Fedele F, Cicero AFG. Lipid-lowering nutraceuticals update on scientific evidence. J Cardiovasc Med (Hagerstown). 2020 Nov;21(11):845-859. doi: 10.2459/JCM.0000000000000970. PMID: 32639326.
20) Lupi A, Ugo F, De Martino L, Infantino V, Iannaccone M, Iorio S, Di Leo A, Colangelo S, Zanera M, Schaffer A, Persampieri S, Garbo R, Senatore G. Real-World Experience With a Tapered Biodegradable Polymer-Coated Sirolimus-Eluting Stent in Patients With Long Coronary Artery Stenoses. Cardiol Res. 2020 Aug;11(4):219-225. doi: 10.14740/cr1055. Epub 2020 Jun 3. PMID: 32595806; PMCID:PMC7295557.
21) Lupi A, Schaffer A, Persampieri S. Acute myocardial infarction presenting with cardiogenic shock in patients with previous coronary artery bypass graft: neglected disease or end-stage condition? Int J Cardiol. 2020 Jul 1;310:25-26. doi: 10.1016/j.ijcard.2020.03.047. Epub 2020 Mar 20. PMID: 32265063.
22) De Luca L, Colivicchi F, Meessen J, Uguccioni M, Piscione F, Bernabò P, Lardieri G, Granatelli A, Gabrielli D, Gulizia MM; EYESHOT Post-MI Investigators. How do cardiologists select patients for dual antiplatelet therapy continuation beyond 1 year after a myocardial infarction? Insights from the EYESHOT Post-MI Study. Clin Cardiol. 2019 Nov 42(11):1113-1120. doi:10.1002/clc.23262. Epub 2019 Aug 31. PMID: 31471975; PMCID: PMC6837024.
23) Rolla R, Lupi A, Bauce G, Appiani A, Portalupi MR, Pergolini P, Rossi L, Giordano M, Bongo AS, Bellomo G. Cardiovascular Risk Profile of Patients Hospitalized for Myocardial Infarction is Undestimated by Traditional Risk Factors and is Better Estimated by a Genetic Analysis Based Upon Single Nucleotide Polymorphisms: A Retrospective Study. J Clin Cardiol Diagn 2018;1(1):1-8.
24) de Winter RJ, Chandrasekhar J, Kalkman DN, Aquino MB, Woudstra P, Beijk MA, Sartori S, Baber U, Tijssen JG, Koch KT, Dangas GD, Colombo A, Mehran R; MASCOT; REMEDEE Registry Investigators. 1-Year Clinical Outcomes of All-Comer Patients Treated With the Dual-Therapy COMBO Stent: Primary Results of the COMBO Collaboration. JACC Cardiovasc Interv. 2018 Oct 8;11(19):1969-1978. doi: 10.1016/j.jcin.2018.04.038. PubMed PMID: 30286855.
25) Casula M, Olmastroni E, Pirillo A, Catapano AL; MEMBERS OF THE LIPIGEN STEERING COMMETTEE; PRINCIPAL INVESTIGATORS: Coordinator center; Participant Centers; Participant Laboratories; COLLABORATORS; STUDY CENTRAL LABORATORY AND ANALYSIS GROUP. Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study. Atherosclerosis. 2018 Oct;277:413-418. doi: 10.1016/j.atherosclerosis.2018.08.013. PubMed PMID:30270079.
26) Valgimigli M, Frigoli E, Leonardi S, Vranckx P, Rothenbühler M, Tebaldi M, Varbella F, Calabrò P, Garducci S, Rubartelli P, Briguori C, Andó G, Ferrario M, Limbruno U, Garbo R, Sganzerla P, Russo F, Nazzaro M, Lupi A, Cortese B, Ausiello A, Ierna S, Esposito G, Ferrante G, Santarelli A, Sardella G, de Cesare N, Tosi P, van ‘t Hof A, Omerovic E, Brugaletta S, Windecker S, Heg D, Jüni P; MATRIX Investigators. Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial. Lancet. 2018 Sep 8;392(10150):835-848. doi: 10.1016/S0140-6736(18)31714-8. Epub 2018 Aug 25. PubMed PMID: 30153988.
27) Lupi A, Bona RD, Meliga E, Capodanno D, Schaffer A, Bongo AS, Gaudio G, Guasti L, Alexopoulos D, Valgimigli M, Porto I. Early P2Y12 Inhibitors Escalation in Primary PCI Patients: Insights from the RENOVAMI Registry. Thromb Haemost. 2018 May;118(5):852-863. doi: 10.1055/s-0038-1635578. Epub 2018 Apr 4. PubMed PMID: 29618159.
28) Lupi A, Schaffer A, Bongo AS. Should ultrathin strut drug eluting stents be considered the new benchmark for novel coronary stents approval? The complex interplay between stent strut thickness, polymeric carriers and antiproliferative drugs. J Thorac Dis. 2018 Feb;10(2):678-681. doi: 10.21037/jtd.2018.01.108. PubMed PMID: 29607133; PubMed Central PMCID: PMC5864588.
29) Gargiulo G, Carrara G, Frigoli E, Vranckx P, Leonardi S, Ciociano N, Campo G, Varbella F, Calabrò P, Garducci S, Iannone A, Briguori C, Andò G, Crimi G, Limbruno U, Garbo R, Sganzerla P, Russo F, Lupi A, Cortese B, Ausiello A, Ierna S, Esposito G, Zavalloni D, Santarelli A, Sardella G, Tresoldi S, de Cesare N, Sciahbasi A, Zingarelli A, Tosi P, van ‘t Hof A, Omerovic E, Brugaletta S, Windecker S, Valgimigli M. Bivalirudin or Heparin in Patients Undergoing Invasive Management of Acute Coronary Syndromes. J Am Coll Cardiol. 2018 Mar 20;71(11):1231-1242. doi: 10.1016/j.jacc.2018.01.033. PubMed PMID: 29544607.
30) Sciahbasi A, Frigoli E, Sarandrea A, Calabrò P, Rubartelli P, Cortese B, Tomassini F, Zavalloni D, Tebaldi M, Calabria P, Rigattieri S, Zingarelli A, Sardella G, Lupi A, Rothenbühler M, Heg D, Valgimigli M. Determinants of radiation dose during right transradial access: Insights from the RAD-MATRIX study. Am Heart J. 2018 Feb;196:113-118. doi: 10.1016/j.ahj.2017.10.014. Epub 2017 Oct 28. PubMed PMID: 29421003.
31) Gargiulo G, Ariotti S, Vranckx P, Leonardi S, Frigoli E, Ciociano N, Tumscitz C, Tomassini F, Calabrò P, Garducci S, Crimi G, Andò G, Ferrario M, Limbruno U, Cortese B, Sganzerla P, Lupi A, Russo F, Garbo R, Ausiello A, Zavalloni D, Sardella G, Esposito G, Santarelli A, Tresoldi S, Nazzaro MS, Zingarelli A, Petronio AS, Windecker S, da Costa BR, Valgimigli M. Impact of Sex on Comparative Outcomes of Radial Versus Femoral Access in Patients With Acute Coronary Syndromes Undergoing Invasive Management: Data From the Randomized MATRIX-Access Trial. JACC Cardiovasc Interv. 2018 Jan 8;11(1):36-50. doi: 10.1016/j.jcin.2017.09.014. PubMed PMID: 29301646.
32) Rognoni A, Cavallino C, Mennuni MG, Barbieri L, Rosso R, Rametta F, Nardi F, Lupi A, Bongo AS. Out-of-hospital cardiac arrest: always coronary angiography? Expert Rev Cardiovasc Ther. 2017 Nov;15(11):847-851. doi: 10.1080/14779072.2017.1376654. Epub 2017 Sep 18. PubMed PMID: 28885062.
33) Guasti L, Gaudio G, Lupi A, D’Avino M, Sala C, Mugellini A, Vulpis V, Felis S, Sarzani R, Vanasia M, Maffioli P, Derosa G. Ambulatory blood pressure parameters after canrenone addition to existing treatment regimens with maximum tolerated dose of angiotensin-converting enzyme inhibitors/angiotensin II type 1 receptor blockers plus hydrochlorothiazide in uncontrolled hypertensive patients. Drug Des Devel Ther. 2017 Aug 4;11:2293-2300. doi: 10.2147/DDDT.S134826. eCollection 2017. PubMed PMID: 28831241; PubMed Central PMCID: PMC5552154.
34) Sciahbasi A, Frigoli E, Sarandrea A, Rothenbühler M, Calabrò P, Lupi A, Tomassini F, Cortese B, Rigattieri S, Cerrato E, Zavalloni D, Zingarelli A, Calabria P, Rubartelli P, Sardella G, Tebaldi M, Windecker S, Jüni P, Heg D, Valgimigli M. Radiation Exposure and Vascular Access in Acute Coronary Syndromes: The RAD-Matrix Trial. J Am Coll Cardiol. 2017 May 23;69(20):2530-2537. doi: 10.1016/j.jacc.2017.03.018. Epub 2017 Mar 18. PubMed PMID: 28330794.
35) Leonardi S, Frigoli E, Rothenbühler M, Navarese E, Calabró P, Bellotti P, Briguori C, Ferlini M, Cortese B, Lupi A, Lerna S, Zavallonito-Parenti D, Esposito G, Tresoldi S, Zingarelli A, Rigattieri S, Palmieri C, Liso A, Abate F, Zimarino M, Comeglio M, Gabrielli G, Chieffo A, Brugaletta S, Mauro C, Van Mieghem NM, Heg D, Jüni P, Windecker S, Valgimigli M; MATRIX Investigators. Bivalirudin or unfractionated heparin in patients with acute coronary syndromes managed invasively with and without ST elevation (MATRIX): randomised controlled trial. BMJ. 2016 Sep 27;354:i4935. doi: 10.1136/bmj.i4935. PubMed PMID: 27677503.
36) Lupi A, Schaffer A, Lazzero M, Tessitori M, De Martino L, Rognoni A, Bongo AS, Porto I. Pre- hospital ticagrelor in patients with ST-segment elevation myocardial infarction with long transport time to primary PCI facility. Cardiovasc Revasc Med. 2016 Dec;17(8):528-534. doi: 10.1016/j.carrev.2016.08.005. PubMed PMID: 27666002.
37) Lupi A, Schaffer A, Rognoni A, Cavallino C, Bongo AS, Cortese B, Jaffe AS, Angiolillo DJ, Porto I. Intracoronary Bivalirudin Bolus in ST-Elevation. Myocardial Infarction Patients Treated with Primary Angioplasty: Theoretical Bases, Clinical Experience, and Future Applications. Am J Cardiovasc Drugs. 2016 Dec;16(6):391-397. PubMed PMID: 27541144.
38) Rognoni A, Cavallino C, Lupi A, Bacchini S, Rosso R, Rametta F, Nardi F, Bongo AS. Ticagrelor: Long-Term Therapy in Patients with Coronary Artery Disease. Rev Recent Clin Trials. 2016;11(4):280-283. PubMed PMID: 27480967.
39) Meliga E, Lupi A, Latib A, Gagnor A, Boccuzzi G, Alcantara M, Lombardi P, Sticchi A, Aranzulla TC, Scrocca I, Varbella F, De Benedictis M, Colombo A, Conte MR. Biolimus Eluting StenT For denovo coRonary artery dIsease in patiENts with Diabetes mellituS: the BESTFRIENDS multicentre registry. J Cardiovasc Med (Hagerstown). 2016 Oct;17(10):729-35. doi: 10.2459/JCM.0000000000000335. PubMed PMID: 26599681.
40) Vidali M, Verzotti E, Cabraz N, Santi F, Puma A, Bellomo G, Lupi A, Lippi G, Avanzi GC. “Real life use” of troponin in the emergency department: a survey of over 3000 cases. Biochemia Medica 2015;25:421–9.
41) Lupi A, Rognoni A, Schaffer A, Secco GG, Bongo AS. Complex Coronary Interventions with the Novel Mozec™ CTO Balloon: The MOZART Registry. Clin Med Insights Cardiol. 2015 Aug 27;9:91-6. doi: 10.4137/CMC.S25552. eCollection 2015. PubMed PMID: 26379450; PubMed Central PMCID: PMC4554352.
42) Valgimigli M, Frigoli E, Leonardi S, Rothenbühler M, Gagnor A, Calabrò P, Garducci S, Rubartelli P, Briguori C, Andò G, Repetto A, Limbruno U, Garbo R, Sganzerla P, Russo F, Lupi A, Cortese B, Ausiello A, Ierna S, Esposito G, Presbitero P, Santarelli A, Sardella G, Varbella F, Tresoldi S, de Cesare N, Rigattieri S, Zingarelli A, Tosi P, van ‘t Hof A, Boccuzzi G, Omerovic E, Sabaté M, Heg D, Jüni P, Vranckx P; MATRIX Investigators. Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes. N Engl J Med. 2015 Sep 10;373(11):997-1009. doi: 10.1056/NEJMoa1507854. Epub 2015 Sep 1. PubMed PMID: 26324049.
43) Lupi A, Rognoni A, Cavallino C, Secco GG, Reale D, Cossa G, Rosso R, Bongo AS, Cortese B, Angiolillo DJ, Jaffe AS, Porto I. Intracoronary vs intravenous bivalirudin bolus in ST-elevation myocardial infarction patients treated with primary angioplasty. Eur Heart J Acute Cardiovasc Care. 2015 Jul 10. pii: 2048872615594499. [Epub ahead of print] PubMed PMID: 26163529.
44) Secco GG, Ghione M, Mattesini A, Dall’Ara G, Ghilencea L, Kilickesmez K, De Luca G, Fattori R, Parisi R, Marino PN, Lupi A, Foin N, Di Mario C. Very h gh-pressure dilatation for undilatable coronary lesions: indications and results with a new dedicated balloon. EuroIntervention. 2015 Jun 26;11(2). pii: 20131217-09. doi: 10.4244/EIJY15M06_04. [Epub ahead of print] PubMed PMID: 26111405.
45) Rognoni A, Degiovanni A, Cavallino C, Lupi A, Rosso R, Veia A, Rametta F, Bongo AS. [Giant aneurysm of the right coronary artery: an unusual treatment]. G Ital Cardiol (Rome). 2015 Apr;16(4):250-3. doi: 10.1714/1848.20192. Italian. PubMed PMID: 25959761.
46) Valgimigli M, Gagnor A, Calabró P, Frigoli E, Leonardi S, Zaro T, Rubartelli P, Briguori C, Andò G, Repetto A, Limbruno U, Cortese B, Sganzerla P, Lupi A, Galli M, Colangelo S, Ierna S, Ausiello A, Presbitero P, Sardella G, Varbella F, Esposito G, Santarelli A, Tresoldi S, Nazzaro M, Zingarelli A, de Cesare N, Rigattieri S, Tosi P, Palmieri C, Brugaletta S, Rao SV, Heg D, Rothenbühler M, Vranckx P, Jüni P; MATRIX Investigators. Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial. Lancet. 2015 Jun 20;385(9986):2465-76. doi: 10.1016/S0140-6736(15)60292-6. Epub 2015 Mar 16. PubMed PMID: 25791214.
47) Lupi A, Rognoni A, Cavallino C, Secco GG, Rosso R, Bongo AS. Ivabradine for Treatment of Coronary Artery Disease: From Last Chance Resort to Mainstem of a Reasoned Therapy. Cardiovasc Hematol Agents Med Chem. 2015;13(1):4-9. PubMed PMID: 25544120.
48) Rognoni A, Cavallino C, Veia A, Bacchini S, Rosso R, Facchini M, Secco GG, Lupi A, Nardi F, Rametta F, Bongo AS. Pathophysiology of Atherosclerotic Plaque Development. Cardiovasc Hematol Agents Med Chem. 2015;13(1):10-3. PubMed PMID: 25544119.
49) Cavallino C, Facchini M, Veia A, Bacchni S, Rognoni A, Rametta F, Lupi A, Bongo AS. New Anti- Anginal Drugs: Ranolazine. Cardiovasc Hematol Agents Med Chem. 2015;13(1) 14-20. PubMed PMID: 25544118.
50) Secco GG, Parisi R, Mirabella F, Rognoni A, Lupi A, De Luca G, Marino PN, Fattori R, Cremonesi A, Castriota F. Old and New Drugs for Treatment of Stable Angina: New Anti Anginal Drugs and Coronary Revascularization. Cardiovasc Hematol Agents Med Chem. 2015;13(1):21-4. PubMed PMID: 25544117.
51) Facchini E, Degiovanni A, Cavallino C, Lupi A, Rognoni A, Bongo AS. Beta-Blockers and Nitrates: Pharmacotherapy and Indications. Cardiovasc Hematol Agents Med Chem. 2015;13(1):25-30. PubMed PMID: 25544116.
52) Valgimigli M; MATRIX investigators. Design and rationale for the Minimizing Adverse haemorrhagic events by TRansradial access site and systemic Implementation of angioX program. Am Heart J. 2014 Dec;168(6):838-45.e6. doi: 10.1016/j.ahj.2014.08.013. Epub 2014 Sep 16. PubMed PMID: 25458646.
53) De Luca L, Leonardi S, Cavallini C, Lucci D, Musumeci G, Caporale R, Abrignani MG, Lupi A, Rakar S, Gulizia MM, Bovenzi FM, De Servi S; EYESHOT investigators. Contemporary antithrombotic strategies in patients with acute coronary syndrome admitted to cardiac care units in Italy: The EYESHOT Study. Eur Heart J Acute Cardiovasc Care. 2015 Oct;4(5):441-52. doi: 10.1177/2048872614560505. Epub 2014 Nov 20. Review. PubMed PMID: 25414322.
54) Lupi A, Rognoni A, Lazzero M, Rolla R, Pergolini P, Bellomo G, Rossi L, Sante Bongo A, Jaffe AS. Below normal pre-procedural cardiac troponin I levels are associated with an adverse prognosis after percutaneous coronary interventions. EuroIntervention. 2014 Nov 19. pii: 20140303-04. doi: 10.4244/EIJY14M11_04. [Epub ahead of print] PubMed PMID: 25405803.
55) Rognoni A, Cavallino C, Lupi A, Secco GG, Veia A, Bacchini S, Rosso R, Brunelleschi S, Rametta F, Bongo AS. Ticagrelor: a novel drug for an old problem. Recent Pat Cardiovasc Drug Discov. 2014;9(1):51-7. Review. PubMed PMID: 25174338.
56) Rognoni A, Cavallino C, Lupi A, Secco GG, Veia A, Bacchini S, Rosso R, Rametta F, Bongo AS. Novel biomarkers in the diagnosis of acute coronary syndromes: the role of circulating miRNAs. Expert Rev Cardiovasc Ther. 2014 Sep;12(9):1119-24. doi: 10.1586/14779072.2014.953483. Review. PubMed PMID: 25160996.
57) Mattesini A, Secco GG, Dall’Ara G, Ghione M, Rama-Merchan JC, Lupi A, Viceconte N, Lindsay AC, De Silva R, Foin N, Naganuma T, Valente S, Colombo A, Di Mario C. ABSORB biodegradable stents versus second-generation metal stents: a comparison study of 100 complex lesions treated under OCT guidance. JACC Cardiovasc Interv. 2014 Jul;7(7):741-50. doi: 10.1016/j.jcin.2014.01.165. PubMed PMID: 25060016.
58) Secco GG, Sansa M, Rognoni A, Parisi R, Fattori R, Rossi L, Lazzero M, Rolla R, Bellomo G, Bongo AS, Agostoni P, Di Mario C, Lupi A. Similar anti-inflammatory effects of intracoronary and intravenous abciximab during primary percutaneous coronary intervention: a randomized study. J Cardiovasc Med (Hagerstown). 2015 Mar;16(3):189-96. doi: 10.2459/JCM 0000000000000119. PubMed PMID: 25022932.
59) Lupi A, Porto I, Rognoni A, Lazzero M, Fattori R, Parisi R, De Maria GL, Bongo AS, Sheiban I, Bolognese L, Agostoni P, Secco GG; Novara-PROMETEUS (Platinum ChROMium Everolimus EluTing StEnt SpontaneoUs RegiStry) Investigators. Clinical and biomechanical behavior of a platinum-chromium stent platform in a large all-comer single-center population: insights from the Novara-PROMETEUS registry. J Invasive Cardiol. 2014 Jul;26(7):311-7. PubMed PMID: 24993987.
60) Lupi A. Editorial (Thematic Issue: Multidisciplinary Imaging of the Coronary Circulation: A Fast Moving Field). Recent Patents in Medical Imaging 2014; 4: 2.
61) Barbieri L, Rognoni A, Secco GG, Cassetti E, Schaffer A, Di Giovine G,Lazzero M, Bongo AS, Marino P, De Luca G, Porto I, Lupi A. Coronary Intravascular Ultrasound (IVUS): Contemporary Applications and Bases for the Future. Recent Patents in Medical Imaging 2014; 4:6-15.
62) Schaffer A, Cassetti E, Di Iovine M, Barbieri L, Rognoni A, Secco GG, Lazzero M, Bongo AS, Porto I, Lupi A. Computed Tomography Imaging of the Coronary Arteries: State of the Art Applications and Recent Patents. Recent Patents in Medical Imaging 2014; 4:22-30.
63) Lupi A, Rognoni A, Lazzero M, Fattori R, De Benedictis M, Sheiban I, Secco GG, Bongo AS. Recent Patents in Imaging of the Vulnerable Atherosclerotic Plaque: The Search for the Holy Grail. Recent Patents in Medical Imaging 2014; 4: 31-40.
64) Colombo F, Zuffi A, Lupi A. Left main dissection complicating blunt chest trauma: case report and review of literature. Cardiovasc Revasc Med. 2014 Sep-Oct;15(6-7):354-6. doi: 10.1016/j.carrev.2014.04.004. Epub 2014 Apr 16. PubMed PMID: 24857266.
65) Rognoni A, Cavallino C, Lupi A, Veia A, Rosso R, Rametta F, Bongo AS. Aortic counterpulsation in cardiogenic shock during acute myocardial infarction. Expert Rev Cardiovasc Ther. 2014 Jul;12(7):913-7. doi: 10.1586/14779072.2014.921116.
66) Giuliani L, Piccinino C, D’Armini MA, Manganiello S, Ferrarotti L, Balbo PE, Lupi A, Marino PN. Prevalence of undiagnosed chronic thromboembolic pulmonary hypertension after pulmonary embolism. Blood Coagul Fibrinolysis. 2014;25:649-53.
67) Lupi A, Secco GG, Rognoni A, Lazzero M, Fattori R, Sheiban I, Bongo AS, Bolognese L, Agostoni P, Porto I. Meta-analysis of bioabsorbable versus durable polymer drug eluting stents in 20,005 patients with coronary artery disease: an update. Catheter Cardiovasc Interv. 2014 May 1;83(6):E193-206. doi: 10.1002/ccd.25416. Epub 2014 Feb 10. Review. PubMed PMID: 24478247.
68) De Luca L, Bolognese L, Valgimigli M, Ceravolo R, Danzi GB, Piccaluga E, Rakar S, Cremonesi A, Bovenzi FM; Gruppo di Lavoro dell’Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO); Societa Italiana di Cardiologia Invasiva (SICI-GISE). [ANMCO/SICI-GISE document on antiplatelet therapy in patients with acute coronary syndrome]. G Ital Cardiol (Rome). 2013 Dec;14(12):839-66. doi: 10.1714/1371.15242. Italian. PubMed PMID: 24336601.
69) Rognoni A, Lupi A, Rosso R, Cavallino C, Bongo AS. Giant bronchial artery aneurysm treated by coil embolization and Amplatzer placement. J Cardiovasc Med (Hagerstown). 2015 Jan;16 Suppl 1:S66-7. doi: 10.2459/JCM.0b013e3283629cc2. PubMed PMID: 24067799.
70) Rognoni A, Barbieri L, Cavallino C, Bacchini S, Veia A, Degiovanni A, Rametta F, Nardi F, Lazzero M, Lupi A, Bongo AS. Ranolazine: effects on ischemic heart. Recent Pat Cardiovasc Drug Discov. 2013 Dec;8(3):197-203. Review. PubMed PMID: 23961914.
71) Lupi A, Rognoni A, Secco GG, Porto I, Nardi F, Lazzero M, Rossi L, Parisi R, Fattori R, Genoni G, Rosso R, Stella PR, Sheiban I, Bolognese L, Liistro F, Bongo AS, Agostoni P. Drug eluting balloon versus drug eluting stent in percutaneous coronary interventions: insights from a meta-analysis of 1462 patients. Int J Cardiol. 2013 Oct 12;168(5):4608-16. doi: 10.1016/j.ijcard.2013.07.161. Epub 2013 Jul 26. Review. PubMed PMID: 23948110.
72) Lupi A, Rognoni A, Secco GG, Bongo AS. Rebuttal to the letter ‘Meta-analysis of biodegradable versus durable polymer drug eluting stents in coronary arterydisease: the reality?’ of Kwong et al. Eur J Prev Cardiol. 2013 Dec;20(6):1033-4. doi: 10.1177/2047487313501238. Epub 2013 Aug 8. PubMed PMID: 23928566.
73) Lupi A, Porto I, Rognoni A, Secco GG, Parisi R, Genoni G, Lazzero M, Bongo AS. Intracoronary bivalirudin: a new way to appease the hostile thrombus? Blood Coagul Fibrinolysis. 2013 Oct;24(7):757-61. doi: 10.1097/MBC.0b013e328361bd2f. PubMed PMID: 23702838.
74) Lupi A, Rognoni A, Cristallini J, Bongo AS. Traps and pitfalls in evaluating a meta-analysis: rebuttal to the letter by Szczesniak et al. Eur J Prev Cardiol. 2013 Jun 20(3):514-5. doi: 10.1177/2047487313485514. Epub 2013 Apr 9. PubMed PMID: 23572480.
75) Rognoni A, Lupi A, Cavallino C, Rosso R, Veia A, Bacchini S, Bongo AS. Intracoronary injection of glycoprotein IIb/IIIa, abciximab, as adjuvant therapy in primary coronary intervention. Cardiovasc Hematol Agents Med Chem. 2013 Jun;11(2):89-95. Review. PubMed PMID: 23394547.
76) Rognoni A, Lupi A, Cavallino C, Veia A, Bacchini S, Rosso R, Secco GG, Bongo AS. Levosimendan preoperative. Curr Pharm Des. 2013;19(22):3974-8. Review. PubMed PMID: 23228313.
77) Lupi A, Rognoni A, Secco GG, Lazzero M, Nardi F, Fattori R, Bongo AS, Agostoni P, Sheiban I. Biodegradable versus durable polymer drug eluting stents in coronary artery disease: insights from a meta-analysis of 5,834 patients. Eur J Prev Cardiol. 2014 Apr;21(4):411-24. doi: 10.1177/2047487312467745. Epub 2012 Nov 14. Review. PubMed PMID: 23152364.
78) Lupi A, Poletti F, Mondino V, Canale C, Leonardo L, Rognoni A, Sante Bongo A, Caimmi PP, Nardi F. Subacute endocarditis caused by Yersinia enterocolitica: a case report. Scand J Infect Dis. 2013 Apr;45(4):329-33. doi: 10.3109/00365548.2012.735371. Epub 2012 Oct 31. PubMed PMID: 23113793.
79) Rognoni A, Santagostino M, Sansa M, Bongo AS, Lupi A. Regarding “Clinical performance of drug- eluting stents with biodegradable polymeric coating: a meta-analysis and systematic review”. EuroIntervention. 2012 Sep;8(5):642-3. doi: 10.4244/EIJV8I5A99. PubMed PMID: 22995094.
80) Rognoni A, Lupi A, Cavallino C, Secco GG, Rosso R, Bongo AS. Intracoronary injection of drugs to treat no–reflow phenomenon and microcirculatory dysfunction. Cardiovasc Hematol Agents Med Chem. 2013 Jun;11(2):84-8. Review. PubMed PMID: 22973862.
81) Secco GG, Parisi R, Mirabella F, Fattori R, Genoni G, Agostoni P, De Luca G, Marino PN, Lupi A, Rognoni A. P2Y12 inhibitors: pharmacologic mechanism and clinical relevance. Cardiovasc Hematol Agents Med Chem. 2013 Jun;11(2):101-5. Review. PubMed PMID: 22963529.
82) Lupi A, Rognoni A, Cavallino C, Secco GG, Prando MD, Santagostino M, Lazzero M, Cassetti E, Bongo AS. Pharmacological adjuvant therapies in primary coronary interventions: bivalirudin. Cardiovasc Hematol Agents Med Chem. 2013 Jun;11(2):106-14. Review. PubMed PMID: 22963495.
83) Secco GG, Bortnik M, Rognoni A, Lupi A, Cavallino C, De Luca G, Marino PN. Stable ventricular fibrillation in a heterotopic heart transplant recipient. Heart Lung Circ. 2012 Nov;21(11):747-9. doi: 10.1016/j.hlc.2012.02.009. Epub 2012 Aug 1. PubMed PMID: 22858206.
84) Lupi A, Rognoni A, Secco GG, Lazzero M, Plebani L, Cossa G, Reale D, Sansa M, Bongo AS, Di Mario C. Comparison of the novel Angio-Seal Evolution with Angio-Seal STS closure device. Perspect Vasc Surg Endovasc Ther. 2012 Mar;24(1):28-36. doi: 10.1177/1531003512442091. Epub 2012 Apr 3. PubMed PMID: 22491159.
85) Lupi A, Rognoni A, Secco GG, Lazzero M, Plebani L, Cossa G, Reale D, Nardi F, Sansa M, Bongo AS. Different spectrum of vascular complications after angio-seal deployment or manual compression. J Invasive Cardiol. 2012 Mar;24(3):90-6. PubMed PMID: 22388297.
86) Rognoni A, Lupi A, Sansa M, Secco GG, Santagostino M, Bongo AS. Radial approach for percutaneous coronary intervention. Rev Recent Clin Trials. 2012 May;7(2):127-32. Review. PubMed PMID: 22353200.
87) Nardi F, Diena M, Caimmi PP, Iraghi G, Lazzero M, Cerin G, Rossi L, Bongo AS, Cernigliaro C, Lupi A. Relationship between left atrial volume and atrial fibrillation following coronary artery bypass grafting. J Card Surg. 2012 Jan;27(1):128-35. doi: 10.1111/j.1540-8191.2011.01373.x. PubMed PMID: 22321120.
88) Rognoni A, Secco GG, Lupi A, Santagostino M, Sansa M, Bongo AS, Rognoni G. Use of endothelial progenitor capture cell stent during percutaneous treatment of coronary bifurcations: a prospective angiographic registry. Crit Pathw Cardiol. 2011 Dec;10(4):189-92. doi: 10.1097/HPC.0b013e318233d57f. PubMed PMID: 22089276.
89) Nardi F, Verna E, Secco GG, Rognoni A, Sante Bongo A, Iraghi G, Bertuol S, Lupi A. Variant angina associated with coronary artery endothelial dysfunction and myocardial bridge: a case report and review of the literature. Intern Med. 2011;50(21):2601-6. Epub 2011 Nov 1. Review. PubMed PMID: 22041365.
90) Lupi A, Secco GG, Rognoni A, Rossi L, Lazzero M, Nardi F, Rolla R, Bellomo G, Bongo AS, Di Mario C. Plasma fibrinogen levels and restenosis after primary percutaneous coronary intervention. J Thromb Thrombolysis. 2012 May;33(4):308-17. doi: 10.1007/s11239-011-0628-z. PMID: 21909639 doi: 10.1007/s11239-011-0628-z. PubMed PMID: 21909639.
91) Rognoni A, Lupi A, Secco GG, Cavallino C, Sansa M, Lazzero M, Bongo AS. Update on glycoprotein IIb/IIIa: role in primary coronary intervention. Cardiovasc Hematol Agents Med Chem. 2011 Apr 1;9(2):106-12. Review. PubMed PMID: 21574947.
92) Lupi A, Lazzero M, Plebani L, Sansa M, Bongo AS. Safety and efficacy of the new Angio-Seal Evolution™ closure device: a single-center experience. J Invasive Cardiol. 2011 Apr;23(4):150-5. PubMed PMID: 21474848.
93) Rognoni A, Lupi A, Lazzero M, Bongo AS, Rognoni G. Levosimendan: from basic science to clinical trials. Recent Pat Cardiovasc Drug Discov. 2011 Jan;6(1):9-15. Review. PubMed PMID: 21208157.
94) Lupi A, Navarese EP, Lazzero M, Sansa M, De Servi S, Serra A, Bongo AS, Buffon A. Drug-eluting stents vs. bare metal stents in saphenous vein graft disease. Insights from a meta-analysis of 7,090 patients. Circ J. 2011;75(2):280-9. Epub 2010 Dec 14. PubMed PMID: 21173499.
95) Navarese EP, Lupi A, Buffon A, De Luca G. “Meta-analysis of ablation of atrial flutter and supraventricular tachycardia”. Am J Cardiol. 2010 Mar 1;105(5):758. doi: 10.1016/j.amjcard.2009.10.011. PubMed PMID: 20185030.
96) Ferraro S, Lupi A, Marano G, Rossi L, Ciardi L, Vendramin C, Bellomo G, Boracchi P, Bongo AS, Biganzoli E. Different patterns of NT-proBNP secretion in acute coronary syndromes. Clin Chim Acta. 2009 Apr;402(1-2):176-81. PubMed PMID: 19263527.
97) Vona M, Mazzuero G, Lupi A, Vettorato C, Bosso P, Cohen-Solal A. Effects of altitude on effort tolerance in non-acclimatized patients with ischemic left ventricular dysfunction. Eur J Cardiovasc Prev Rehabil. 2006 Aug;13(4):617-24. PubMed PMID: 16874154.
98) Trani C, Giordano A, Lombardo A, Lupi A, Reale F, Patrizi R, Patrizi G, Mazzari MA, Schiavoni G, Maseri A. Selective intracoronary injection of sestamibito detect myocardial viability: Prediction of perfusion and contractile recovery after percutaneous transluminal coronary angioplasty. J Nucl Cardiol. 2003 Sep-Oct;10(5):473-81. PubMed PMID: 14569240.
99) Rizzo S, Giudice M, Lupi A, Frigiola A, Guerra F. [False mass in the left atrium… or better: true mass in false atrium]. Ital Heart J Suppl. 2001 Oct;2(10):1121-3. Italian. PubMed PMID: 11723617.
100) Rizzo S, Lupi A, Cristallini P, Mobilia G, De Marchi M. [Large thrombus in non-aneurysmal descending aorta and peripheral embolism: report of a case and review of the literature]. Ital Heart J Suppl. 2001 Jun;2(6):676-80. Review. Italian. PubMed PMID: 11460844.
101) Gaudino M, Glieca F, Trani C, Lupi A, Mazzari MA, Schiavoni G, Possati G. Midterm endothelial function and remodeling of radial artery grafts anastomosed to the aorta. J Thorac Cardiovasc Surg. 2000 Aug;120(2):298-301. PubMed PMID: 10917946.
102) Lupi A, Trani C, Gaudino M, Canosa C, Di Sciascio G, Ramazzotti V, Alessandrini F, Mazzari MA, Schiavoni G, Possati G. [Remodelling of the radial artery graft 5 years after aortocoronary bypass intervention]. Cardiologia. 1999 Apr;44(4):381-4. Italian. PubMed PMID: 10371791.
103) Lanza GA, Guido V, Galeazzi MM, Mustilli M, Natali R, Ierardi C, Milici C, Burzotta F, Pasceri V, Tomassini F, Lupi A, Maseri A. Prognostic role of heart rate variability in patients with a recent acute myocardial infarction. Am J Cardiol. 1998 Dec 1;82(11):1323-8. PubMed PMID: 9856913.
104) Lupi A, Lanza GA, Lucente M, Crea F, Proietti I, Maseri A. The “warm-up” phenomenon occurs in patients with chronic stable angina but not in patients with syndrome X. Am J Cardiol. 1998 Jan 15;81(2):123-7. PubMed PMID: 9591891.
105) Lupi A, Buffon A, Finocchiaro ML, Conti E, Maseri A, Crea F. Mechanisms of adenosine-induced epicardial coronary artery dilatation. Eur Heart J. 1997 Apr;18(4):614-7. PubMed PMID: 9129891.
106) Maseri A, Crea F, Lupi A. [The role of coronary vasomotoricity in ischemic cardiopathy: fluctuating preconceptions]. Cardiologia. 1996 Jan;41(1):19-30. Review. Italian. PubMed PMID: 8697465.
107) Finocchiaro ML, Buffon A, Beltrame JF, Lupi A, Conti E, Lanza GA, Cianflone D, Crea F, Maseri A. Differences in vasodilatory response to dipyridamole between patients with angina and normal coronary arteries and patients with successful coronary angioplasty. Coron Artery Dis. 1995 Jun;6(6):479-87. PubMed PMID: 7551269.
108) Lupi A, Secco GG, Rognoni A, Lazzero M, Sansa M, Bongo AS. Transradial Primary Angioplasty in a Patient With Congenital Abnormality of the Forearm Circulation and Increased Bleeding Risk. Cardiac Cath Lab Director 2011; 1: 115-7.
109) Navarese EP, Lupi A, Buffon A, Sansa M, Franchi E, Aurelio A, Bongo AS. Meta-analysis of non- randomized studies in interventional cardiology: a critical appraisal. JPH 2009; 6: 303-6.
110) Andreotti F, Prevost R, Lupi A, Hamilton J, de Bart ACW, Huisman LGM, Maseri A, Kluft C. Circadian patterns of plasma t.PA and PAl-1 antigen levels in patients with severe peripheral atherosclerosis. Fibrinolysis 1996; 10 Supp 2: 159-160.

Capitoli di libri di teso

  1. Nardi F, Lupi A“Complicanze meccaniche acute nell’infarto miocardico”, pp27-40 in “Ecocardiografia in emergenza-urgenza”, Edizioni Minerva Medica, 2012
  2. Lupi A, Rognoni A, Bongo AS. Nuovi anticoagulanti orali nelle sindromi coronariche acute, pp 141-150, in “Nuovi anticoagulanti orali: indicazioni e utilizzo nella pratica clinica”, Edizioni Minerva Medica, 2013

Libri di testo

  1. Nardi F, Bongo AS, Cimminiello C, Iraghi G, Lupi A. “Nuovi anticoagulanti orali: indicazioni e utilizzo nella pratica clinica”, Edizioni Minerva Medica, 2013

Collaborazioni editoriali

  • Associate Editor of the “ESC Heart failure” Journal
  • Editorial board of the “Clinical Medicine Insights: Cardiology” Journal
  • Guest reviewer for many cardiology journals (Atherosclerosis, thrombosis and vascular biology, Catheterization & cardiovascular interventions, International Journal of Cardiology, Thrombosis & Haemostasis, Atherosclerosis; 30 reviews in the last year).

Affiliazioni a società scientifiche:

  • Fellow of the Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO)
  • Fellow of the Society for Cardiocascular angiography and Interventions (SCAI)
  • ESC membership through the Italian Federation of Cardiology
  • ESC Working Group on Coronary Pathophysiology and Microcirculation membership
  • ESC Working Group on Atherosclerosis and Vascular Biology membership
  • Acute Cardiovascular Care Association membership
  • European Association of Percutaneous Cardiovascular Interventions (EAPCI) membership